What is the Price Targets for Applied DNA Sciences Inc. (APDN)?

Applied DNA Sciences Inc. (NASDAQ:APDN) saw an upside of 20.42% to close Tuesday at $5.72 after adding $0.97 on the day. The 5-day average trading volume is 509,180 shares of the company’s common stock. It has gained $5.82 in the past week. An average of 214,710 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 778,476.

APDN’s 1-month performance is 0.18% or -$0.09 on its low of $4.65 reached on 10/08/21. The company’s shares have touched a 52-week low of $4.65 and high of $13.64, with the stock’s rally to the 52-week high happening on 02/11/21. YTD, APDN has achieved 12.16% or $0.62. However, the current price is down -58.06%% from the 52-week high price.

A Backdoor Way To Profit From Today’s Crypto Bull Market

In any crypto bull market, there's a lot of money to be made.

But what if we told you the best opportunities are not cryptocurrencies themselves… but instead, simply crypto stocks?

This strategy is simply and ridiculously easy.

Here are 6 ways to gain exposure to crypto outside the norm. This is arguably the safest bet you can make.


Insider Transactions

On Mar 10, 217 days have gone by since the last insider trading activity for Applied DNA Sciences Inc. (APDN). Anchin Scott L (Director) most recently sold 13,049 shares at $8.43 per share on Mar 10. This transaction cost the insider $110,042.

Valuation Metrics

Applied DNA Sciences Inc. (APDN) has a trailing price-to-earnings (P/E) ratio of 26.50 for the broader industry and 28.48 for the sector.APDN stock has a beta of 1.00. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 7.14 while the price-to-book (PB) in the most recent quarter is 2.75.

Applied DNA Sciences Inc.’s quick ratio for the period ended June 29 was 8.40, with the current ratio over the same period at 8.70 meaning that APDN stock is able to fulfill its debt obligations. As well, the company’s long term debt to equity for the quarter ending June 29 was 0.00, while the total debt to equity was 0.00. In terms of profitability, the gross margin trailing 12 months is 79.30%. The trailing 12-month EBITDA margin is -634.19%. The firm’s gross profit as reported stood at $1.21 million against revenue of $1.93 million.

Earnings Surprise

For the quarterly period ending June 29 this year, Net income and sales went down compared to those figures reported in the previous quarter. Analysts expected APDN to announce -$0.26 per share in earnings in its latest quarter, but it posted -$0.46, representing a -76.90% surprise. EBITDA for the quarter stood at more than -$3.12 million. APDN stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 1.61 million. Shareholders hold equity totaling $7.49 million

Technical Picture

Let’s look briefly at Applied DNA Sciences Inc. (APDN) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 12 October was 63.42% to suggest the stock is trending Neutral, with historical volatility in this time period at 106.47%.

The stock’s 5-day moving average is $5.00, reflecting a +10.42% or $0.54 change from its current price. APDN is currently trading +4.00% above its 20-day SMA, -5.61% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 and SMA200 by +5.34% and +5.54% respectively.

Stochastic %K and %D was 29.85% and 13.22% and the average true range (ATR) pointed at 0.35. The RSI (14) points at 57.07%, while the 14-day stochastic is at 79.85% with the period’s ATR at 0.33. The stock’s 9-day MACD Oscillator is pointing at -0.06 and -0.19 on the 14-day charts.

Analyst Ratings

In the most recent analyst report for Applied DNA Sciences Inc. (NASDAQ: APDN), ROTH Capital launched coverage with a Buy rating. Analysts offering their rating for APDN stock have a consensus rating for the stock as Buy. Currently, 0 brokerage advisors rate APDN as a “sell,”, while 0 advise that investors “Hold.” 0 analysts have rated the stock as underweight. 0 rates the stock as overweight while 3 have offered a “buy” rating.

What is APDN’s price target for the next 12 months?

Analysts have a consensus price target ranging from a low of $11.00 and a high of $24.00, with their median price target at $18.00. Looking at these predictions, the average price target given by analysts is for Applied DNA Sciences Inc. (APDN) stock is $17.67.


Please enter your comment!
Please enter your name here


Hot Topics

Related Videos

Related Videos

Related Articles



Download Free eBook For



100% free. stop anytime no spam